Great Leadership By Dan

JUNE 14, 2018

The field that provides this kind of know-how is called ethics. This means that ethics is serious business. Ethical dilemmas are at least as hard to resolve as engineering problems, and at least as urgent, particularly in our complex and fast-moving world. When does pharmaceutical pricing become price gouging?

Ethics 197

Ethics Maturity Analysis Cost-Benefit Analysis 197

Talent Anarchy 1

AUGUST 25, 2023

In today’s ever-evolving job market, individuals are constantly on the lookout for career paths that promise stability, growth, and fulfillment. One such path that often flies under the radar is consumer non-durables a good career path. But is it a good career path?

Career 78

Career Supply Chain Pharmaceuticals Industry 78

HR Digest

NOVEMBER 10, 2021

Having joined the world’s largest pharmaceutical company, she is now out to raise the bar for human resources leadership across the organization. ECRGs offer support, developmental opportunities, mentoring and networking opportunities to help members enhance their skills, foster allyship and inclusion, and help advance their careers.

Diversity 102

Diversity Commitment Learning-by-Doing Globalization 102

Harvard Business Review

MARCH 24, 2017

The onus for ethical behavior falls first to the employee. Most companies talk a good ethics game and even make their goals public. Compensation should be tied to broad-based outcomes and include things such as customer satisfaction and product knowledge, in addition to success at closing deals. Consider the case of GSK.

Ethics 8

Ethics Company Incentives Policies 8

Harvard Business Review

NOVEMBER 5, 2015

I love my career in competitive strategy, research, and teaching. As a child I felt no particular interest in pharmaceuticals, telecommunications, computers, oil and gas, health and beauty aids, medical devices, airlines, or shipbuilding, all of which I’ve simulated or war-gamed. It engages my mind. Then they grow up.

Career 8

Career Seminar Self-aware Telecommunications 8

Harvard Business Review

JUNE 9, 2017

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. During our careers, we have worked in industry, academia, clinical medicine, and government and have managed successful academia-industry collaborations.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10